{"id":8604,"date":"2023-10-01T23:10:04","date_gmt":"2023-10-01T23:10:04","guid":{"rendered":"https:\/\/mdxcro.com\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/"},"modified":"2026-07-28T14:05:57","modified_gmt":"2026-07-28T14:05:57","slug":"guia-mdcg-2020-13-dispositivos-medicos","status":"publish","type":"post","link":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/","title":{"rendered":"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de productos sanitarios que preparan informes de evaluaci\u00f3n cl\u00ednica"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The <a href=\"https:\/\/health.ec.europa.eu\/medical-devices-dialogue-between-interested-parties\/medical-device-coordination-group-working-groups_en\">Medical Device Coordination Group (MDCG)<\/a> shapes how medical devices are assessed in the European Union. One of its most influential documents is\u00a0<strong>MDCG 2020-13<\/strong>, a guideline that explains how manufacturers should prepare Clinical Evaluation Reports (CERs) under the EU Medical Device Regulation (MDR). For any company aiming to place a device on the EU market, understanding\u00a0<strong>MDCG 2020-13 for Manufacturers<\/strong>\u00a0is essential.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong>Why MDCG 2020-13 Matters for Manufacturers<\/strong><\/h2>\n\n<p class=\"wp-block-paragraph\">The MDR introduced a stricter and far more structured compliance framework. Clinical Evaluation Reports are no longer a formality\u2014they are central to demonstrating safety, performance, and clinical benefit.<\/p>\n\n<p class=\"wp-block-paragraph\"><strong>MDCG 2020-13 for Manufacturers<\/strong>\u00a0provides the roadmap for building a CER that meets MDR expectations. Aligning with this guidance improves the quality of your Technical Documentation and significantly strengthens your chances of regulatory approval.<\/p>\n\n<p class=\"wp-block-paragraph\">Clinical evaluation is now a continuous process, and MDCG 2020-13 ensures manufacturers understand\u00a0<strong>what data to collect, how to justify it, and how to present it<\/strong>.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong>How MDCG 2020-13 Shapes the <a href=\"https:\/\/mdxcro.com\/es\/informe-de-evaluacion-clinica-mdr-se-explican-las-funciones-de-meddev-y-mdcg\/\">Clinical Evaluation Process<\/a><\/strong> (CER)<\/h2>\n\n<p class=\"wp-block-paragraph\">MDCG 2020-13 serves as a practical reference for structuring clinical evidence. It explains what the CER must include and aligns its structure with MDR Annex XIV, ensuring manufacturers remain fully compliant with current regulations.<\/p>\n\n<p class=\"wp-block-paragraph\">The guideline helps manufacturers:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Understand the level of clinical data required<\/li>\n\n\n\n<li>Present evidence in a regulatory\u2011ready format<\/li>\n\n\n\n<li>Show benefit\u2011risk alignment with MDR safety principles<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\"><strong>For manufacturers, this guidance reduces ambiguity and supports consistent, defensible clinical evaluations.<\/strong><\/p>\n\n<h2 class=\"wp-block-heading\"><strong>What You Need to Know About Aligning CERs With the CEAR Format<\/strong><\/h2>\n\n<p class=\"wp-block-paragraph\">Manufacturers may structure their Clinical Evaluation Report to follow the\u00a0<strong>Clinical Evaluation Assessment Report (CEAR)<\/strong>\u00a0used by Notified Bodies.<br\/>Why does this matter?<\/p>\n\n<ul class=\"wp-block-list\">\n<li>It creates a smoother review process<\/li>\n\n\n\n<li>It improves clarity and traceability<\/li>\n\n\n\n<li>It anticipates NB expectations<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Using the CEAR structure is not mandatory, but it can streamline regulatory interactions and reduce back\u2011and\u2011forth during conformity assessments.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong>Key Goals of the <a href=\"https:\/\/mdxcro.com\/es\/5-pasos-para-disenar-la-plantilla-de-tu-plan-de-evaluacion-clinica\/\">Clinical Evaluation Plan<\/a> Under MDCG 2020\u201113<\/strong><\/h2>\n\n<p class=\"wp-block-paragraph\">MDCG 2020-13 reinforces the importance of a well\u2011defined\u00a0<strong>Clinical Evaluation Plan (CEP)<\/strong>. Manufacturers must align it with MDR Annex XIV Part A Section 1a. The CEP should clearly define:<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 General Safety and Performance Requirements (GSPRs)<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Identify which GSPRs require clinical evidence and describe how that evidence will be generated.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Intended Purpose<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Ensure consistency across the CER, IFU, labeling, and promotional materials.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Target Populations and Indications<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Include patient groups, contraindications, and specific clinical conditions.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Clinical Benefits and Outcome Measures<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Define measurable clinical outcomes linked to meaningful patient benefit.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Clinical Safety Methods<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Explain how both qualitative and quantitative aspects of safety will be assessed.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Benefit\u2011Risk Parameters<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">List all metrics and criteria used to justify the benefit\u2011risk determination.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Special Considerations for Combination Products<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Address components such as medicinal substances, tissues of animal origin, or human derivatives.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Clinical Development Plan<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Include milestones and acceptance criteria\u2014even if only high level.<\/p>\n\n<p class=\"wp-block-paragraph\">A well\u2011designed CEP sets the foundation for a successful clinical evaluation and a strong CER.<\/p>\n\n<h1 class=\"wp-block-heading\"><strong>Aligning IFU, Promotional Materials, and the CER Using MDCG 2020-13<\/strong><\/h1>\n\n<p class=\"wp-block-paragraph\">One of the most practical aspects of\u00a0<strong>MDCG 2020-13 for Manufacturers<\/strong>\u00a0is its guidance on aligning all outward\u2011facing documents with the CER.<\/p>\n\n<p class=\"wp-block-paragraph\">Here\u2019s what manufacturers must evaluate:<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Information Materials<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Review IFUs, labeling, SSCPs, and promotional materials to ensure they reflect the evidence presented in the CER.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Intended Purpose<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">The intended purpose described in the CER must match exactly what appears in the IFU and promotional claims.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Patient Population and User Groups<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Ensure consistency in population definitions and user profiles (HCP vs. lay user).<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Warnings, Contraindications, and Precautions<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Verify that safety information in the IFU is backed by data in the CER and risk management file.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Training Requirements<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">If user training is needed, justify this in both the risk management documentation and the CER.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Associated Risks and Residual Risks<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Ensure risk descriptions align across the CER, IFU, PMS\/PSUR, and RMF.<\/p>\n\n<p class=\"wp-block-paragraph\">This alignment not only supports MDR compliance but also ensures safe, transparent communication to patients and users.<\/p>\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"has-white-frost-color has-blue-background-color has-text-color has-background has-link-color has-medium-font-size wp-elements-f5d2de36d49042c12ddf2827aa8ba85c wp-block-paragraph\">By aligning these documents in accordance with MDCG 2020-13, manufacturers not only assure compliance but also build a strong foundation for market success, bolstered by robust clinical evidence and transparent communication.<\/p>\n<\/blockquote>\n\n<h2 class=\"wp-block-heading\">How to Incorporate these Aspects in Your Clinical Evaluation<\/h2>\n\n<h3 class=\"wp-block-heading\"><strong>1. Start With a Gap Analysis<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Compare your existing CER and CEP against the MDCG 2020-13 requirements.<br\/>This identifies missing data, unclear claims, or inconsistencies.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>2. Use a Multidisciplinary Team<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Combine expertise from clinical, regulatory, engineering, and risk management.<br\/>This ensures your CER is scientifically sound and fully compliant.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>3. Update Documentation<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Revise the CEP, CER, and supporting Technical Documentation based on identified gaps.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>4. Ensure Consistent Device Descriptions<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Match the device description across the CER, IFU, marketing materials, and SSCP.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>5. Integrate All Available Clinical Data<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Include pre\u2011clinical data, clinical investigations, PMS results, PMCF findings, and real\u2011world evidence.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>6. Leverage PMS and PSUR Insights<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Use post\u2011market data to strengthen the CER and ensure continuous compliance.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>7. Align With the Risk Management File<\/strong><\/h3>\n\n<p class=\"wp-block-paragraph\">Make sure risk\u2011related statements remain consistent across all documents.<\/p>\n\n<p class=\"wp-block-paragraph\">By taking these steps, manufacturers can confidently align with\u00a0<strong>MDCG 2020-13<\/strong>, strengthen their clinical evidence, and support a smooth Notified Body review.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-color\">Why MDCG 2020-13 for Manufacturers Is a Strategic Advantage<\/mark><\/strong><\/h2>\n\n<p class=\"wp-block-paragraph\">This guideline is far more than a compliance requirement. It helps manufacturers:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Build stronger, defensible clinical evidence<\/li>\n\n\n\n<li>Reduce regulatory delays<\/li>\n\n\n\n<li>Improve device safety and performance claims<\/li>\n\n\n\n<li>Strengthen market readiness<\/li>\n\n\n\n<li>Ensure consistent messaging across all documentation<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">With MDCG 2020-13, manufacturers can elevate the quality and credibility of their clinical evaluations\u2014while accelerating time\u2011to\u2011market under the MDR.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Medical Device Coordination Group (MDCG) shapes how medical devices are assessed in the European Union. One of its most influential documents is\u00a0MDCG 2020-13, a guideline that explains how manufacturers should prepare Clinical Evaluation Reports (CERs) under the EU Medical Device Regulation (MDR). For any company aiming to place a device on the EU market, [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":5903,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[216],"tags":[],"resources-sector":[180],"class_list":["post-8604","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-2","resources-sector-medical-devices"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MDCG 2020-13 para fabricantes | MDx CRO<\/title>\n<meta name=\"description\" content=\"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MDCG 2020-13 para fabricantes | MDx CRO\" \/>\n<meta property=\"og:description\" content=\"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/\" \/>\n<meta property=\"og:site_name\" content=\"MDx CRO\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-01T23:10:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-28T14:05:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"David Tome\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"David Tome\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/\"},\"author\":{\"name\":\"David Tome\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#\\\/schema\\\/person\\\/2f4b7210469032b3479db2c180b4eabd\"},\"headline\":\"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de productos sanitarios que preparan informes de evaluaci\u00f3n cl\u00ednica\",\"datePublished\":\"2023-10-01T23:10:04+00:00\",\"dateModified\":\"2026-07-28T14:05:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/\"},\"wordCount\":930,\"publisher\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_77960083-scaled-e1696197274511.jpeg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/\",\"name\":\"MDCG 2020-13 para fabricantes | MDx CRO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_77960083-scaled-e1696197274511.jpeg\",\"datePublished\":\"2023-10-01T23:10:04+00:00\",\"dateModified\":\"2026-07-28T14:05:57+00:00\",\"description\":\"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_77960083-scaled-e1696197274511.jpeg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_77960083-scaled-e1696197274511.jpeg\",\"width\":640,\"height\":427,\"caption\":\"Banderas de la Uni\u00f3n Europea en una instalaci\u00f3n m\u00e9dica de alta tecnolog\u00eda ilustran la colaboraci\u00f3n global y la innovaci\u00f3n en las aceleraciones de MedTech y el crecimiento de la tecnolog\u00eda sanitaria.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/guia-mdcg-2020-13-dispositivos-medicos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de dispositivos m\u00e9dicos que preparan informes de evaluaci\u00f3n cl\u00ednica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/\",\"name\":\"MDx CRO\",\"description\":\"Investigaci\u00f3n cl\u00ednica, normativa y control de calidad en tecnolog\u00eda m\u00e9dica y diagn\u00f3stico in vitro\",\"publisher\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#organization\"},\"alternateName\":\"MDx\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#organization\",\"name\":\"CRO de MDx\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/MDX.svg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/MDX.svg\",\"width\":352,\"height\":114,\"caption\":\"CRO de MDx\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/medtech-ivd-cro\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#\\\/schema\\\/person\\\/2f4b7210469032b3479db2c180b4eabd\",\"name\":\"David Tome\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/cropped-David-Tome-1-96x96.jpg\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/cropped-David-Tome-1-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/cropped-David-Tome-1-96x96.jpg\",\"caption\":\"David Tome\"},\"description\":\"David is a recognized expert in clinical research and medical device regulation (MDR\\\/IVDR). He is currently President and former Head of Clinical Operations at MDx CRO, a strategic consulting firm that helps MedTech and IVD companies bring their technologies from patent to market in the EU and the U.S. With over 15 years of experience leading clinical operations at industry giants such as Philips and Olympus, he combines his executive role with teaching as a visiting professor at business schools and universities (ESAME, CEU). He specializes in clinical project management, obtaining CE Marking, and developing clinical evaluation reports (CER\\\/PER).\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/autor\\\/david-tome\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MDCG 2020-13 para fabricantes | MDx CRO","description":"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/","og_locale":"es_ES","og_type":"article","og_title":"MDCG 2020-13 para fabricantes | MDx CRO","og_description":"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.","og_url":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/","og_site_name":"MDx CRO","article_published_time":"2023-10-01T23:10:04+00:00","article_modified_time":"2026-07-28T14:05:57+00:00","og_image":[{"width":640,"height":427,"url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","type":"image\/jpeg"}],"author":"David Tome","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"David Tome","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/#article","isPartOf":{"@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/"},"author":{"name":"David Tome","@id":"https:\/\/mdxcro.com\/es\/#\/schema\/person\/2f4b7210469032b3479db2c180b4eabd"},"headline":"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de productos sanitarios que preparan informes de evaluaci\u00f3n cl\u00ednica","datePublished":"2023-10-01T23:10:04+00:00","dateModified":"2026-07-28T14:05:57+00:00","mainEntityOfPage":{"@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/"},"wordCount":930,"publisher":{"@id":"https:\/\/mdxcro.com\/es\/#organization"},"image":{"@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/#primaryimage"},"thumbnailUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","articleSection":["Blog"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/","url":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/","name":"MDCG 2020-13 para fabricantes | MDx CRO","isPartOf":{"@id":"https:\/\/mdxcro.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/#primaryimage"},"image":{"@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/#primaryimage"},"thumbnailUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","datePublished":"2023-10-01T23:10:04+00:00","dateModified":"2026-07-28T14:05:57+00:00","description":"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.","breadcrumb":{"@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/#primaryimage","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","width":640,"height":427,"caption":"Banderas de la Uni\u00f3n Europea en una instalaci\u00f3n m\u00e9dica de alta tecnolog\u00eda ilustran la colaboraci\u00f3n global y la innovaci\u00f3n en las aceleraciones de MedTech y el crecimiento de la tecnolog\u00eda sanitaria."},{"@type":"BreadcrumbList","@id":"https:\/\/mdxcro.com\/es\/guia-mdcg-2020-13-dispositivos-medicos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mdxcro.com\/es\/"},{"@type":"ListItem","position":2,"name":"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de dispositivos m\u00e9dicos que preparan informes de evaluaci\u00f3n cl\u00ednica"}]},{"@type":"WebSite","@id":"https:\/\/mdxcro.com\/es\/#website","url":"https:\/\/mdxcro.com\/es\/","name":"MDx CRO","description":"Investigaci\u00f3n cl\u00ednica, normativa y control de calidad en tecnolog\u00eda m\u00e9dica y diagn\u00f3stico in vitro","publisher":{"@id":"https:\/\/mdxcro.com\/es\/#organization"},"alternateName":"MDx","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mdxcro.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/mdxcro.com\/es\/#organization","name":"CRO de MDx","url":"https:\/\/mdxcro.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/mdxcro.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg","width":352,"height":114,"caption":"CRO de MDx"},"image":{"@id":"https:\/\/mdxcro.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/medtech-ivd-cro"]},{"@type":"Person","@id":"https:\/\/mdxcro.com\/es\/#\/schema\/person\/2f4b7210469032b3479db2c180b4eabd","name":"David Tome","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/09\/cropped-David-Tome-1-96x96.jpg","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/09\/cropped-David-Tome-1-96x96.jpg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/09\/cropped-David-Tome-1-96x96.jpg","caption":"David Tome"},"description":"David is a recognized expert in clinical research and medical device regulation (MDR\/IVDR). He is currently President and former Head of Clinical Operations at MDx CRO, a strategic consulting firm that helps MedTech and IVD companies bring their technologies from patent to market in the EU and the U.S. With over 15 years of experience leading clinical operations at industry giants such as Philips and Olympus, he combines his executive role with teaching as a visiting professor at business schools and universities (ESAME, CEU). He specializes in clinical project management, obtaining CE Marking, and developing clinical evaluation reports (CER\/PER).","url":"https:\/\/mdxcro.com\/es\/autor\/david-tome\/"}]}},"_links":{"self":[{"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/posts\/8604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/comments?post=8604"}],"version-history":[{"count":3,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/posts\/8604\/revisions"}],"predecessor-version":[{"id":11772,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/posts\/8604\/revisions\/11772"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/media\/5903"}],"wp:attachment":[{"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/media?parent=8604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/categories?post=8604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/tags?post=8604"},{"taxonomy":"resources-sector","embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/resources-sector?post=8604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}